These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 39267012)

  • 21. Self-collection and pooling of samples as resources-saving strategies for RT-PCR-based SARS-CoV-2 surveillance, the example of travelers in French Polynesia.
    Aubry M; Teiti I; Teissier A; Richard V; Mariteragi-Helle T; Chung K; Deen F; Paoaafaite T; Cao-Lormeau VM
    PLoS One; 2021; 16(9):e0256877. PubMed ID: 34473769
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exit and Entry Screening Practices for Infectious Diseases among Travelers at Points of Entry: Looking for Evidence on Public Health Impact.
    Mouchtouri VA; Christoforidou EP; An der Heiden M; Menel Lemos C; Fanos M; Rexroth U; Grote U; Belfroid E; Swaan C; Hadjichristodoulou C
    Int J Environ Res Public Health; 2019 Nov; 16(23):. PubMed ID: 31766548
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Barriers and facilitators to COVID-19 screening at Jaipur International Airport, India.
    Mantri N; Joshi NK; Bhardwaj P; Goel AD; Gupta MK; Singh K; Misra S
    J Family Med Prim Care; 2022 Oct; 11(10):5969-5982. PubMed ID: 36618255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. COVID-19 Rapid Antigen Test as Screening Strategy at Points of Entry: Experience in Lazio Region, Central Italy, August-October 2020.
    Colavita F; Vairo F; Meschi S; Valli MB; Lalle E; Castilletti C; Fusco D; Spiga G; Bartoletti P; Ursino S; Sanguinetti M; Di Caro A; Vaia F; Ippolito G; Capobianchi MR
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33805832
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Incidence and Predictors of Imported Cases of COVID-19 in Burkina Faso.
    Kaboré M; Sondo KA; Dahourou DL; Cissoko Y; Konaté I; Zaré A; Bicaba B; Ouedraogo B; Barro H; Diendéré EA; Asamoah I; Damoue SN; Siri BAA; Diallo I; Puplampu P; Poda AG; Toloba Y; Dao S; Ouédraogo M; Kouanda S
    Front Public Health; 2022; 10():743248. PubMed ID: 35252079
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SARS-CoV-2 Testing Before International Airline Travel, December 2020 to May 2021.
    Tande AJ; Binnicker MJ; Ting HH; Del Rio C; Jalil L; Brawner M; Carter PW; Toomey K; Shah ND; Berbari EF
    Mayo Clin Proc; 2021 Nov; 96(11):2856-2860. PubMed ID: 34736612
    [TBL] [Abstract][Full Text] [Related]  

  • 27. COVID-19 passenger screening to reduce travel risk and translocation of disease.
    Waite LL; Nahhas A; Irvahn J; Garden G; Kerfonta CM; Killelea E; Ferng W; Cummins JJ; Mereness R; Austin T; Jones S; Olson N; Wilson M; Isaac B; Pepper CA; Koolhof IS; Armstrong J
    Epidemiol Infect; 2024 Feb; 152():e36. PubMed ID: 38326275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Travel-associated SARS-CoV-2 transmission documented with whole genome sequencing following a long-haul international flight.
    Ngeh S; Vogt F; Sikazwe CT; Levy A; Pingault NM; Smith DW; Effler PV
    J Travel Med; 2022 Sep; 29(6):. PubMed ID: 35532195
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Airport Traveler Testing Program for SARS-CoV-2 - Alaska, June-November 2020.
    Ohlsen EC; Porter KA; Mooring E; Cutchins C; Zink A; McLaughlin J
    MMWR Morb Mortal Wkly Rep; 2021 Apr; 70(16):583-588. PubMed ID: 33886533
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Logistic advantage of two-step screening strategy for SARS-CoV-2 at airport quarantine.
    Yokota I; Shane PY; Teshima T
    Travel Med Infect Dis; 2021; 43():102127. PubMed ID: 34174408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. COVID-19 cases reported in Colorado following screening at selected US airports, January - July 2020.
    Shaum A; Harlow T; Gulati RK; Berro A; House J
    BMC Res Notes; 2023 Apr; 16(1):67. PubMed ID: 37106467
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of border control measures and community containment measures used in Japan during the early stages of Pandemic (H1N1) 2009.
    Sakaguchi H; Tsunoda M; Wada K; Ohta H; Kawashima M; Yoshino Y; Aizawa Y
    PLoS One; 2012; 7(2):e31289. PubMed ID: 22355354
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel strategy for SARS-CoV-2 mass screening with quantitative antigen testing of saliva: a diagnostic accuracy study.
    Yokota I; Shane PY; Okada K; Unoki Y; Yang Y; Iwasaki S; Fujisawa S; Nishida M; Teshima T
    Lancet Microbe; 2021 Aug; 2(8):e397-e404. PubMed ID: 34031649
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Universal COVID-19 screening of 4040 health care workers in a resource-limited setting: an Egyptian pilot model in a university with 12 public hospitals and medical centers.
    Mostafa A; Kandil S; El-Sayed MH; Girgis S; Hafez H; Yosef M; Saber S; Ezzelarab H; Ramadan M; Afifi I; Hassan F; Elsayed S; Reda A; Fattuh D; Mahmoud A; Mansour A; Sabry M; Habeb P; Ebeid FS; Saleh A; Mansour O; Omar A; El-Meteini M
    Int J Epidemiol; 2021 Mar; 50(1):50-61. PubMed ID: 33094320
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cross-sectional survey of SARS-CoV-2 testing at US airports and one health department's proactive management of travelers.
    Shaum A; Figueroa A; Lee D; Ertl A; Rothney E; Borntrager D; Davenport E; Gulati RK; Brown CM
    Trop Dis Travel Med Vaccines; 2022 Mar; 8(1):8. PubMed ID: 35305682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Usefulness of aircraft and airport wastewater for monitoring multiple pathogens including SARS-CoV-2 variants.
    Tay M; Lee B; Ismail MH; Yam J; Maliki D; Gin KY; Chae SR; Ho ZJM; Teoh YL; Ng LC; Wong JCC
    J Travel Med; 2024 Jul; 31(5):. PubMed ID: 38813965
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Public health measures at the airport of Hamburg during the early phase of pandemic influenza (H1N1) 2009].
    Schlaich C; Sevenich C; Gau B
    Gesundheitswesen; 2012 Mar; 74(3):145-53. PubMed ID: 21305451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.
    Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ;
    Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SARS-CoV-2 RT-PCR as a universal screening on planned admission in asymptomatic patients.
    Yamamoto C; Nukui Y; Furukawa K; Taniguchi M; Yamano T; Inaba T; Kikai R; Tanino Y; Yamada Y; Teramukai S; Takayama K
    J Infect Chemother; 2024 Jul; 30(7):668-671. PubMed ID: 38135218
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevention of SARS-CoV-2 transmission from international arrivals: Xiaotangshan Designated Hospital, China.
    Luo Z; Zhang Y; Zheng Y; MacIntyre CR; Liang Y; Wang Q; Ma Y
    Bull World Health Organ; 2021 May; 99(5):374-380. PubMed ID: 33958825
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.